Andrew Sinclair - 05 Jun 2024 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role: Director
Signature: /s/ Nick Harvey, Attorney-in-Fact
Issuer symbol: ACET
Transactions as of: 05 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 07 Jun 2024, 16:03:42 UTC
Previous filing: 16 Aug 2023
Next filing: 10 Jun 2024
SEC: View on sec.gov

Key filing fact

Andrew Sinclair filed Form 4 for Adicet Bio, Inc. (ACET) on 07 Jun 2024.

Key facts

This page summarizes Andrew Sinclair's Form 4 filing for Adicet Bio, Inc. (ACET).
2 reported transactions and 1 derivative row are listed below.
Filing timestamp: 07 Jun 2024, 16:03.

Change

Previous filing in this sequence was filed on 16 Aug 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

ACET transaction

Common Stock

Award

Transaction value: $0
Shares: +5,900
Change %: +100%
Price: $0.000000
Shares after: 11,800
Date: 05 Jun 2024
Ownership: Direct
Footnotes: F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

ACET transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +26,400
Change %
Price: $0.000000
Shares after: 26,400
Date: 05 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,400
Exercise price: $1.44
Footnotes: F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was issued Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
F2	These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors.

Content

The Reporting Person was issued Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.

These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors.